2-(4-methoxyphenyl)-4-[3-methyl-1-phenyl-5-(1,2,4-triazol-1-yl)pyrazol-4-yl]pyrimido[1,2-a]benzimidazole
C29H22N8O — CID 155525023
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-methoxyphenyl)-4-[3-methyl-1-phenyl-5-(1,2,4-triazol-1-yl)pyrazol-4-yl]pyrimido[1,2-a]benzimidazole
2-(4-methoxyphenyl)-4-[3-methyl-1-phenyl-5-(1,2,4-triazol-1-yl)pyrazol-4-yl]pyrimido[1,2-a]benzimidazole (PubChem CID 155525023) has the molecular formula C29H22N8O and a molecular weight of 498.55 g/mol. Its IUPAC name is 2-(4-methoxyphenyl)-4-[3-methyl-1-phenyl-5-(1,2,4-triazol-1-yl)pyrazol-4-yl]pyrimido[1,2-a]benzimidazole.
Molecular Properties
| Compound Name | 2-(4-methoxyphenyl)-4-[3-methyl-1-phenyl-5-(1,2,4-triazol-1-yl)pyrazol-4-yl]pyrimido[1,2-a]benzimidazole |
|---|---|
| PubChem CID | 155525023 |
| Molecular Formula | C29H22N8O |
| Molecular Weight | 498.55 g/mol |
| Exact Mass | 498.19 |
| IUPAC Name | 2-(4-methoxyphenyl)-4-[3-methyl-1-phenyl-5-(1,2,4-triazol-1-yl)pyrazol-4-yl]pyrimido[1,2-a]benzimidazole |
| SMILES | COc1ccc(-c2cc(-c3c(C)nn(-c4ccccc4)c3-n3cncn3)n3c(n2)nc2ccccc23)cc1 |
| InChI | InChI=1S/C29H22N8O/c1-19-27(28(35-18-30-17-31-35)37(34-19)21-8-4-3-5-9-21)26-16-24(20-12-14-22(38-2)15-13-20)33-29-32-23-10-6-7-11-25(23)36(26)29/h3-18H,1-2H3 |
| InChIKey | RHBZVNNTJIGWAA-UHFFFAOYSA-N |
| XLogP | 5.30 |
| TPSA | 87.95 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 498.55 |
| LogP ≤ 5 | 5.30 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155525023 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.